Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Numerous GLP-1RAs are currently available on the market, and each agent possesses a unique biochemical profile, depending the alterations made to its backbone, human GLP-1, or exendin-4 (Fig
I., Sakai, K., Kaida, Y., Yokoro, M., Ueda, S.,
Branchfield K, Nantie L, Verheyden JM, Sui P, Wienhold MD, Sun X
In the intervention group, prandial insulin was discontinued and basal insulin reduced to 80% of the home dose or converted to glargine at 40% of the total daily dose for patients on premixed regimens
US$ 23.63
US$ 23.46
US$ 21.54
US$ 27.13
US$ 20.62
US$ 23.48
US$ 28.20
US$ 24.04
